|
Vaccine Detail
P. aeruginosa PcrV Protein Vaccine |
Vaccine Information |
- Vaccine Name: P. aeruginosa PcrV Protein Vaccine
- Target Pathogen: Pseudomonas aeruginosa
- Target Disease: Pseudomonas aeruginosa infection
- Vaccine Ontology ID: VO_0004191
- Type: Subunit vaccine
- Status: Research
- Antigen: PcrV
- PcrV
gene engineering:
- Type: Recombinant protein preparation
- Description: PcrV was produced as a lipopolysaccharide-free histidine-tagged infusion protein in pET16b and was purified by nickel chromatography (Holder et al., 2001).
- Detailed Gene Information: Click Here.
- Adjuvant: incomplete Freund's adjuvant
- Immunization Route: Intramuscular injection (i.m.)
|
Host Response |
Mouse Response
- Host Strain: CF-1
- Vaccination Protocol: On day 0, groups of 10 female CF-1 mice weighing 22 to 25 g were immunized intramuscularly in the hind leg (10 μg of immunogen in 0.1 ml of incomplete Freund's adjuvant), followed by a booster dose (10 μg in saline) without adjuvant on day 14 (Holder et al., 2001).
- Challenge Protocol: Using the burned mouse model, mice were challenged by one of three strains of P. aeruginosa (Holder et al., 2001).
- Efficacy: Burned Pseudomonas aeruginosa-infected mice immunized against PcrV, a type III virulence system translocating protein, showed significantly enhanced survival compared to controls (Holder et al., 2001).
|
References |
Holder et al., 2001: Holder IA, Neely AN, Frank DW. PcrV immunization enhances survival of burned Pseudomonas aeruginosa-infected mice. Infection and immunity. 2001; 69(9); 5908-5910. [PubMed: 11500471].
|
|